About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 18,951 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,951 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1021-1040 of 18,951 trials

TerminatedAn Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman SyndromeThis open-label study (OV101-18-002) will evaluate the long-term (52 weeks) safety of OV101 in subjects with AS and provide additional OV101 treatment to those subjects who…NCT03882918·Phoenix, Arizona and 10 others TerminatedA Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous InjectionsThis study will investigate the safety of three fixed dose levels of tanezumab (2.5 mg, 5 mg, and 10 mg) administered at an 8-week interval by subcutaneous injection multiple (7)…NCT00994890·Mobile, Alabama and 99 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

Active not recruitingA Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without InhibitorsThis study will test how well a new medicine called concizumab works for participants who have haemophilia A or B with or without inhibitors.NCT05135559·San Diego, California and 90 others

TerminatedPalbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsThis phase I trial studies the side effects and best dose of palbociclib isethionate in treating younger patients with central nervous system tumors that have grown, come back, or…NCT02255461·Los Angeles, California and 10 others

CompletedOptic Nerve Sheath FenestrationThe purpose of this study is to develop a way to perform safer surgery in the eye socket.NCT00337961·Nashville, Tennessee

RecruitingCollection and Storage of Tissue and Blood Samples From Patients With CancerThis study collects and stores tissue and blood samples from patients with cancer.NCT02474160·Birmingham, Alabama and 139 others

Active not recruitingColonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)Colorectal cancer (CRC) is currently the second most common cause of cancer death in the United States, and one of the most preventable cancers.NCT01239082·Phoenix, Arizona and 45 others

CompletedA Study to Investigate the Effect of Renal Function and Hemodialysis on the Pharmacokinetics (PK) of RO7079901This is a multi-center, non-randomized, open-label, two-part study to investigate the effect of renal function and hemodialysis on PK of RO7079901.NCT02975388·Miami, Florida and 4 others

TerminatedCombined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke RiskThe IMPACT Study will investigate the potential clinical benefit of the combined use of BIOTRONIK Home Monitoring (HM) technology and a predefined anticoagulation plan compared to…NCT00559988·Phoenix, Arizona and 79 others

RecruitingEffect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSThis is a placebo-controlled, randomized, double-blind, parallel group, phase 3 multicenter study in subjects recently hospitalized for ACS and with the appropriate genetic…NCT05918861·Alexander City, Alabama and 230 others

TerminatedA Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell MalignanciesThe purpose of this study is to evaluate the safety, tolerability, dose-limiting toxicities (any harmful effect of a drug) (DLT), maximum tolerated dose (MTD), recommended Phase 2…NCT02454270·Detroit, Michigan and 19 others

CompletedProtein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney DiseaseNational Kidney Foundation guidelines recommend a dietary protein intake of 1.2 grams per kilogram per day (g/kg/d) in hemodialysis patients.NCT00566670·Nashville, Tennessee and 1 other

RecruitingA Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) InfusionImmunoglobulin light chain (AL) amyloidosis is the most common form of systemic amyloidosis.NCT06158854·Miami, Florida and 22 others

Active not recruitingA U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of CareThis observational research study is to better understand patients with eosinophilic esophagitis (EoE) who have recently been prescribed DUPIXENT® (dupilumab).NCT06693531·Phoenix, Arizona and 53 others

CompletedA Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).The study will assess the efficacy, safety, and immunogenicity of PF-06410293 and adalimumab in combination with methotrexate in subjects with moderately to severly active…NCT02480153·Gilbert, Arizona and 182 others

RecruitingA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesThe purpose of this study is to assess the efficacy and safety of enicepatide, a dual glucagon like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor…NCT07351045·Anniston, Alabama and 202 others

TerminatedVELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid ArthritisThis is a multi-national, multi-centre, placebo-controlled, double-blind, randomized, 4-arm parallel group trial, comparing three different dose levels (80 mg, 160 mg and 320 mg)…NCT01390545·La Mesa, California and 62 others

CompletedA Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.The primary objective is to compare the efficacy between three doses of AZD0865 (25, 50 and 75 mg).NCT00206245·Alabaster, Alabama and 201 others

RecruitingBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)This is a study to evaluate the efficacy and safety of belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL), pancreatic neuroendocrine tumor…NCT04924075·Los Angeles, California and 83 others

CompletedLong-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus ErythematosusThe main objective of the trial is to characterize the long-term safety and tolerability of BMS-986165 in subjects with Systemic Lupus Erythematosus (SLE).NCT03920267·Birmingham, Alabama and 97 others

PreviousPage 52 of 948Next

Diabetes

in Tennessee

Heart Diseasein Tennessee